Royal Seal of Approval for Pioneering Silicone Ostomy Product Improving Quality of Life for Patients - European Medical Journal
×

Browse

Royal Seal of Approval for Pioneering Silicone Ostomy Product Improving Quality of Life for Patients

|
Gastroenterology
3 Mins

London, UK, 21 April, 2018

A life changing silicone adhesive that prevents abdominal stomas from leaking and provides a range of benefits for patients and healthcare professionals, has been awarded the prestigious Queen’s Award for Enterprise.

Privately-owned Trio Healthcare was presented the award under the Innovation category for its breakthrough patented silicone technology, which is improving the lives of ostomates around the world. It is the UK’s most prestigious business accolade which recognises the benefits offered to ostomates and their unique needs.

Abdominal stomas are surgically created intestinal openings which are a result of treating conditions such as colorectal and bladder cancer, Crohn’s or colitis. The stoma outputs body waste such as faeces and urine which is then collected in an odour-proof bag. At one time or another, all ostomates will suffer from leakage and therefore damaged to the skin, which has a dramatic impact on their social life and psychological wellbeing.

To combat this, Trio has developed a unique, secure adhesive known as Trio Responsive® Silicone, that can be used around the stoma to provide a skin-friendly seal and a long awaited alternative solution to hydrocolloid. The company’s R&D team have focused on using a non-hydrocolloid technology to develop their innovation using silicone polymers.

By modifying the chemical make-up of the silicone formulation, Trio has developed a secure but comfortable solution that allows the skin to breathe normally, even perspire, whilst maintaining a secure connection. The patented formulation leaves no residue and its waterproof nature prevents absorption of any faeces or urine providing a complete barrier, which allows the skin to naturally heal underneath.

The development of the pioneering technology – which is manufactured in house -has enabled Trio to launch a revolutionary range of silicone-based accessory products in an industry dominated by hydrocolloid. These products are seen as a precursor to the natural next phase of ostomy products coming out of Trio’s pipeline.  The company is currently in the development phase of a new, innovative ostomy system to complete the range.

Lloyd Pearce, Managing Director from Trio, said: “We are delighted to win such a prestigious award for our contribution to ostomy care. Due to the stigma and embarrassment associated with body waste and bag leakage, a person’s social life and well-being is dependent on the ostomy adhesive and bag’s performance.

“Too many people around the world were suffering from leakage and irritated skin, so as a company we have made it our mission to provide an alternative solution . Our products offer reassurance and comfort, so the wearer can get on with their everyday lives without fear of sore skin.”

The Queen’s Awards are presented each year by Her Majesty Queen Elizabeth II on her birthday, 21st April, on the advice of the Prime Minister, assisted by an advisory committee comprising representatives of Government, industry, commerce and the trade unions. The company will attend a reception at Buckingham Palace in June, hosted by HRH Prince of Wales.

This is the second time Trio Healthcare have been the recipients of a Queen’s Award for Enterprise. In 2011 they were awarded the Queen’s Award – International Trade. The company have offices in both Buckinghamshire and North Yorkshire.

For more information visit: TrioOstomyCare.com 

Notes to Editors

More information about Trio Healthcare

Trio Healthcare is a privately-owned company with offices in two UK locations – Great Missenden, Buckinghamshire and Skipton, North Yorkshire. They are dedicated to the provision of life enhancing healthcare solutions and have a strong history in developing innovative and advanced medical technologies.

Direct contact with patients and clinicians, has enabled Trio to fully appreciate the clinical and psychological problems that their products treat. All their products are developed in close consultation with patients and clinicians, ensuring their popularity when they are introduced to the wider community.

Trio has an overriding commitment to patient care with improvements to quality of life being at the heart of their business. They ensure all their products reach healthcare providers at an affordable level, offering the benefits of the most advanced silicone technology for all.

 

Contacts